Idioma:

Development of a human papillomavirus type 6/11 vaccine candidate for the prevention of condyloma acuminatum

Yu, Yue ; Guo, Jianfeng ; Li, Dingfeng ; Liu, Yong ; Yu, Yongli ; Wang, Liying

Vaccine, 2018-08, Vol.36 (32), p.4927-4934 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por

Enviar para

Título:
Development of a human papillomavirus type 6/11 vaccine candidate for the prevention of condyloma acuminatum
Autor: Yu, Yue ; Guo, Jianfeng ; Li, Dingfeng ; Liu, Yong ; Yu, Yongli ; Wang, Liying
Assuntos: Aluminum ; Aluminum phosphate ; Antibodies ; Antibodies, Neutralizing - immunology ; Antibodies, Viral - immunology ; Antigens ; Chromatography, Gel ; Condyloma acuminatum ; Condylomata Acuminata - immunology ; Condylomata Acuminata - prevention & control ; Conflicts of interest ; Dismantling ; Electrophoresis, Polyacrylamide Gel ; Genes ; Growth rate ; Hansenula polymorpha ; Health care ; High performance liquid chromatography ; Human papillomavirus ; Human papillomavirus 11 - immunology ; Human papillomavirus 11 - pathogenicity ; Human papillomavirus 6 - immunology ; Human papillomavirus 6 - pathogenicity ; Humans ; Immunization ; Immunogenicity ; Immunoglobulins ; Light scattering ; Liquid chromatography ; Males ; Mice ; Monkeys ; Papillomaviridae - immunology ; Papillomaviridae - pathogenicity ; Papillomavirus Infections - immunology ; Papillomavirus Infections - prevention & control ; Papillomavirus Vaccines - immunology ; Papillomavirus Vaccines - therapeutic use ; Pichia pastoris ; Prevention ; Proteins ; Quality of life ; Transmission electron microscopy ; Vaccine ; Vaccines ; Vaccines, Virus-Like Particle - therapeutic use ; Vectors (Biology) ; Virus-like particles ; Viruses
É parte de: Vaccine, 2018-08, Vol.36 (32), p.4927-4934
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: •Development of a specific prophylactic HPV6/11 vaccine for condyloma acuminatum.•The HPV6/11 vaccine provides a good choice for prevention of CA in males.•The HPV 6/11 L1 VLPs were produced in Hansenula polymorpha with correct structure.•The HPV6/11 vaccine shows high immunogenicity in both mice and cynomolgus monkeys. Condyloma acuminatum (CA) represents a significant human papillomavirus (HPV) disease burden worldwide, resulting in substantial healthcare costs and loss of life quality in both genders. To address this problem, we tried to develop a bivalent HPV6/11 virus-like particle (VLP) vaccine targeting CA. HPV6/11 VLPs were generated in Hansenula polymorpha, and a disassembly and reassembly (D/R) treatment was further conducted to improve the stability and monodispersity of the VLPs. The HPV6/11 VLPs were identified by transmission electron microscopy (TEM), high performance liquid chromatography (HPLC), mass spectrum (MS) and dynamic light scattering (DLS), and were evaluated for their immunogenicity in both mice and cynomolgus monkeys. The results showed that the HPV6/11 L1 proteins were correctly expressed and assembled into HPV6/11 VLPs, and the HPV6/11 VLPs formulated with aluminum phosphate induced vigorous production of specific neutralizing antibodies against HPV6/11 VLPs in mice and cynomolgus monkeys. These data indicated that the Hansenula polymorpha-derived HPV6/11 VLPs could be formulated into a bivalent vaccine used in prevention of CA.
Editor: Netherlands: Elsevier Ltd
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 4 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Development of a human papillomavirus type 6/11 vaccine candidate for the prevention of condyloma acuminatum

Yu, Yue ; Guo, Jianfeng ; Li, Dingfeng ; Liu, Yong ; Yu, Yongli ; Wang, Liying

Netherlands: Elsevier Ltd

Buscando em bases de dados remotas. Favor aguardar.